The researchers usually send the protocol for 'independent scientific review' or 'peer review'.
This means that people with the right experience and qualifications look through the protocol to make sure it is all correct.
They point out any difficulties that the researchers might have overlooked. They also check how the results will be worked out (analysed). Often the protocol will often be reviewed by patients to get their perspective.
Trustees Joanna Barker D.Litt (Chairman), Lisa Attenborough, Sylvia Auton, Sonya Branch, Mike Holt (Hon Treasurer), Kate Kirkland and Helen MacNamara
Patrons Professor Sir Kenneth Calman PhD MD FRCS FRCP, Dame Janet Gaymer DBE QC
Chief Executive Annwen Jones
Target Ovarian Cancer is a company limited by guarantee, registered in England and Wales (No. 6619981). Registered office: 30 Angel Gate, London EC1V 2PT. Registered charity numbers 1125038 (England and Wales) and SC042920 (Scotland).